Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

V. Ellen Maher,Laura L. Fernandes,Chana Weinstock,Shenghui Tang,Sundeep Agarwal,Michael Holman Brave,Yang Min Ning,Harpreet Singh,Daniel L. Suzman,James Xu,Kirsten B. Goldberg,Rajeshwari Sridhara,Amna Ibrahim,Marc Robert Theoret,Julia A. Beaver,Richard Pazdur

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

2019

V. Ellen Maher
Laura L. Fernandes
Chana Weinstock
Shenghui Tang
Sundeep Agarwal
Michael Holman Brave
Yang Min Ning
Harpreet Singh
Daniel L. Suzman
James Xu
Kirsten B. Goldberg
Rajeshwari Sridhara
Amna Ibrahim
Marc Robert Theoret
Julia A. Beaver
Richard Pazdur

PURPOSETo assess the relationship among tumor response rate, overall survival, and the development of related adverse events of special interest (AESIs) or related immune-mediated adverse events (i...

Keywords:

Response rate (survey)
Antibody
Pathology
Oncology
Internal medicine
Medicine
Adverse effect
in patient
tumor response
overall survival
programmed death

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

100

Citations